Odyssey Therapeutics, Inc. ODTX
$18.00
▲ +0.54% 24H
About
Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with autoimmune and inflammatory diseases. The company advances a pipeline of small molecule and protein therapeutics that target upstream signaling nodes in the innate immune system to preve…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees100
TickerODTX
Statistics
Market Cap$849.1M
Revenue (TTM)$3.1M
Net Income—
Net Margin—
EPS—
P/E—
P/S275.10
P/B—
EV/EBITDA-4.68
ROE-85.5%
Dividend Yield—
Price$18.00
Data: Twelve Data · Revenue = mcap / P/S